Sweden’s life science industry is experiencing rapid growth, boasting top talent, cutting-edge R&D, and highly specialised manufacturing capabilities that are addressing global health challenges.

Life sciences represent one of the largest export categories and stand as a testament to the nation’s long-standing commitment to medical innovation and scientific excellence. In a unique ecosystem with world-class research institutions, collaborating closely with industry to drive breakthrough discoveries, we continue to shape the future of global healthcare and science through cutting-edge research and development.

  • Pharmaceuticals (medical and pharmaceutical products) are Sweden's second largest export product group in 2024: Sweden's export and import products (SCB) (151Md SEK, 2024)
  • Annual R&D investments of EUR 5 billion in Life Sciences
  • 4,000 companies and a high rate of university spinouts
  • Large exporter of pharmaceutical products (EUR 15 billion annually)
  • Unique IP rights for academic research enable early-stage commercialization
  • Open research infrastructure with an extensive network of biobanks and health data registries
  • Extensive infrastructure for Advanced Therapy Medicinal Products (ATMP)
  • A healthcare system welcoming industry-sponsored clinical trials, with a National Coordination Center for Clinical Trials, supporting the launch of your study across all healthcare regions.


How would you like to engage with the Swedish life sciences? Contact us today and we'll help you get there.